Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY

v3.8.0.1
STOCKHOLDERS' EQUITY
3 Months Ended
Mar. 31, 2018
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
NOTE 8 – STOCKHOLDERS’ EQUITY
 
Common Stock Issued in Option Exercise
 
During the three months ended March 31, 2017, the Company issued 3,491 shares of common stock as the result of the cashless exercise of 4,100 options. The exercise price of the options was $2.00 per share. The Company retained 609 shares of common stock valued at $13.47 for an aggregate of $8,200 as the exercise price.
 
Common Stock Issued in Public Offering – In February 2018, the Company closed on an underwritten public offering of 6,164,000 shares of its common stock, including 804,000 shares sold pursuant to the full exercise of an over-allotment option, at $14.00 per share for gross proceeds of $86,296,000. Total net proceeds from the offering were $81,822,066, after deducting underwriting commissions and offering expenses payable by the Company of $4,473,934.